MAPP® has received 510(k) approval from FDA

30 August, 2021

MAPP® App suite has received 510(k) approval from FDA, which means that it can be marketed as a medical device in United States.

This has been a long process that has been completed in August and will allow us to focus on a very developed market with great potential.

We maintain our goal to reach a larger number of Hospitals ensuring Clinical Safety to all Patients receiving care with our apps.

More News

MAPP® solutions in the Divino Espírito Santo Hospital of Ponta Delgada.

In December, we started the implementation of MAPP® solutions in the Divino Espírito Santo Hospital of Ponta Delgada. BIQ Health Solutions is the partner chosen to support HDES in this […]

+

Security and Compliance Certifications

At BIQ Health Solutions, information security and regulatory compliance are essential pillars of our healthcare solutions. Given the critical nature of clinical and hospital data, we continuously invest in rigorous […]

+

BTRAC, CareTRAC and LabTRAC – Lusíadas Amadora Hospital

BIQ Health Solutions continues to strengthen its commitment to improving healthcare and its professionals. The Lusíadas Amadora Hospital Unit – of Lusíadas Saúde, has recently expanded the use of the […]

+

BIQ Health Solutions in the World